CA2 and esophageal adenocarcinoma: The expression of CA2 remains controversial in different cancers, it was reported to be upregulated in urinary bladder cancers [21], and CA2 autoantibody titers in gastric cancer patients were found higher compared to healthy subjects [22], while in esophageal adenocarcinoma, its expression was downregulated [23].